Company Who this page is about. 1 identity field
Company location
Hackensack, NJ
SEC filing record 1 source field
Fiscal year end
31 December
Protalix BioTherapeutics, Inc. has filed 957 SEC EDGAR filings since 13 Aug 1996

SEC filing history

Showing 301-325 of 671 matching filings.

Per page
25
Current page
13
SC 13G/A File 005-50118

AMENDMENT NO. 2 TO SCHEDULE 13G

Filing date
12 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-50118

AMENDMENT NO. 3 TO SCHEDULE 13G

Filing date
12 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-50118

SC 13G/A

Filing date
08 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
05 Feb 2019
Reporting date
05 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
10 Jan 2019
Reporting date
10 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
04 Jan 2019
Reporting date
04 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
27 Dec 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-33357

DEFA14A

Filing date
19 Dec 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

8-K

Filing date
17 Dec 2018
Reporting date
17 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
13 Dec 2018
Reporting date
13 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
04 Dec 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-33357

CT ORDER filing

Filing date
04 Dec 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
07 Nov 2018
Reporting date
07 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-33357

DEFINITIVE PROXY STATEMENT

Filing date
17 Oct 2018
Reporting date
13 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-33357

PRELIMINARY PROXY STATEMENT

Filing date
05 Oct 2018
Reporting date
13 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
05 Oct 2018
Reporting date
05 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
21 Sep 2018
Reporting date
21 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
14 Sep 2018
Reporting date
13 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
14 Sep 2018
Reporting date
13 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
14 Sep 2018
Reporting date
13 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
14 Sep 2018
Reporting date
13 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
14 Sep 2018
Reporting date
13 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
13 Aug 2018
Reporting date
09 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
13 Aug 2018
Reporting date
09 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .